"Multi-component reactions: Emerging chemistry in drug discovery" 'from Xylocain to Crixivan'

Christopher Hulme, Vijay Gore

Research output: Contribution to journalArticle

959 Citations (Scopus)

Abstract

With the recent emergence of combinatorial chemistry and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest. Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compounds, often in one step and high yield. Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as 'non drug-like'. This review details developments of new, highly atom-economic MCR derived chemical methods, which enable the fast and efficient production of chemical libraries comprised of a variety of biologically relevant templates. Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clinical process development arenas. This will include applications spanning biological tools, natural products and natural product-like diversity, traditional small molecule and 'biotech' therapeutics respectively. In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.

Original languageEnglish (US)
Pages (from-to)51-80
Number of pages30
JournalCurrent Medicinal Chemistry
Volume10
Issue number1
DOIs
StatePublished - 2003
Externally publishedYes

Fingerprint

Indinavir
Drug Discovery
Biological Products
Small Molecule Libraries
Cyanides
Economics
Peptides
Byproducts
Pharmaceutical Preparations
Atoms
Molecules
Therapeutics
Lead

ASJC Scopus subject areas

  • Organic Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Pharmacology

Cite this

"Multi-component reactions : Emerging chemistry in drug discovery" 'from Xylocain to Crixivan'. / Hulme, Christopher; Gore, Vijay.

In: Current Medicinal Chemistry, Vol. 10, No. 1, 2003, p. 51-80.

Research output: Contribution to journalArticle

@article{0c99634d141b4512850efda68e9aa4e7,
title = "{"}Multi-component reactions: Emerging chemistry in drug discovery{"} 'from Xylocain to Crixivan'",
abstract = "With the recent emergence of combinatorial chemistry and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest. Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compounds, often in one step and high yield. Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as 'non drug-like'. This review details developments of new, highly atom-economic MCR derived chemical methods, which enable the fast and efficient production of chemical libraries comprised of a variety of biologically relevant templates. Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clinical process development arenas. This will include applications spanning biological tools, natural products and natural product-like diversity, traditional small molecule and 'biotech' therapeutics respectively. In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.",
author = "Christopher Hulme and Vijay Gore",
year = "2003",
doi = "10.2174/0929867033368600",
language = "English (US)",
volume = "10",
pages = "51--80",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - "Multi-component reactions

T2 - Emerging chemistry in drug discovery" 'from Xylocain to Crixivan'

AU - Hulme, Christopher

AU - Gore, Vijay

PY - 2003

Y1 - 2003

N2 - With the recent emergence of combinatorial chemistry and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest. Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compounds, often in one step and high yield. Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as 'non drug-like'. This review details developments of new, highly atom-economic MCR derived chemical methods, which enable the fast and efficient production of chemical libraries comprised of a variety of biologically relevant templates. Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clinical process development arenas. This will include applications spanning biological tools, natural products and natural product-like diversity, traditional small molecule and 'biotech' therapeutics respectively. In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.

AB - With the recent emergence of combinatorial chemistry and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest. Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compounds, often in one step and high yield. Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as 'non drug-like'. This review details developments of new, highly atom-economic MCR derived chemical methods, which enable the fast and efficient production of chemical libraries comprised of a variety of biologically relevant templates. Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clinical process development arenas. This will include applications spanning biological tools, natural products and natural product-like diversity, traditional small molecule and 'biotech' therapeutics respectively. In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.

UR - http://www.scopus.com/inward/record.url?scp=0037238724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037238724&partnerID=8YFLogxK

U2 - 10.2174/0929867033368600

DO - 10.2174/0929867033368600

M3 - Article

C2 - 12570721

AN - SCOPUS:0037238724

VL - 10

SP - 51

EP - 80

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 1

ER -